Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

435 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Molecular analysis of the HuD gene in neuroendocrine lung cancers.
D'Alessandro V, Muscarella LA, la Torre A, Bisceglia M, Parrella P, Scaramuzzi G, Storlazzi CT, Trombetta D, Kok K, De Cata A, Sperandeo M, Zelante L, Carella M, Vendemiale G. D'Alessandro V, et al. Among authors: kok k. Lung Cancer. 2010 Jan;67(1):69-75. doi: 10.1016/j.lungcan.2009.03.022. Lung Cancer. 2010. PMID: 19410329
Keap1/Nrf2 pathway in kidney cancer: frequent methylation of KEAP1 gene promoter in clear renal cell carcinoma.
Fabrizio FP, Costantini M, Copetti M, la Torre A, Sparaneo A, Fontana A, Poeta L, Gallucci M, Sentinelli S, Graziano P, Parente P, Pompeo V, De Salvo L, Simone G, Papalia R, Picardo F, Balsamo T, Flammia GP, Trombetta D, Pantalone A, Kok K, Paranita F, Muscarella LA, Fazio VM. Fabrizio FP, et al. Among authors: kok k. Oncotarget. 2017 Feb 14;8(7):11187-11198. doi: 10.18632/oncotarget.14492. Oncotarget. 2017. PMID: 28061437 Free PMC article.
Genomic organization and evolution of double minutes/homogeneously staining regions with MYC amplification in human cancer.
L'Abbate A, Macchia G, D'Addabbo P, Lonoce A, Tolomeo D, Trombetta D, Kok K, Bartenhagen C, Whelan CW, Palumbo O, Severgnini M, Cifola I, Dugas M, Carella M, De Bellis G, Rocchi M, Carbone L, Storlazzi CT. L'Abbate A, et al. Among authors: kok k. Nucleic Acids Res. 2014 Aug;42(14):9131-45. doi: 10.1093/nar/gku590. Epub 2014 Jul 17. Nucleic Acids Res. 2014. PMID: 25034695 Free PMC article.
Gene amplification as double minutes or homogeneously staining regions in solid tumors: origin and structure.
Storlazzi CT, Lonoce A, Guastadisegni MC, Trombetta D, D'Addabbo P, Daniele G, L'Abbate A, Macchia G, Surace C, Kok K, Ullmann R, Purgato S, Palumbo O, Carella M, Ambros PF, Rocchi M. Storlazzi CT, et al. Among authors: kok k. Genome Res. 2010 Sep;20(9):1198-206. doi: 10.1101/gr.106252.110. Epub 2010 Jul 14. Genome Res. 2010. PMID: 20631050 Free PMC article.
A chronic obstructive pulmonary disease related signature in squamous cell lung cancer.
Boelens MC, Gustafson AM, Postma DS, Kok K, van der Vries G, van der Vlies P, Spira A, Lenburg ME, Geerlings M, Sietsma H, Timens W, van den Berg A, Groen HJ. Boelens MC, et al. Among authors: kok k. Lung Cancer. 2011 May;72(2):177-83. doi: 10.1016/j.lungcan.2010.08.014. Epub 2010 Sep 15. Lung Cancer. 2011. PMID: 20832896
Combined osimertinib, dabrafenib and trametinib treatment for advanced non-small-cell lung cancer patients with an osimertinib-induced BRAF V600E mutation.
Meng P, Koopman B, Kok K, Ter Elst A, Schuuring E, van Kempen LC, Timens W, Hiltermann TJN, Groen HJM, van den Berg A, van der Wekken AJ. Meng P, et al. Among authors: kok k. Lung Cancer. 2020 Aug;146:358-361. doi: 10.1016/j.lungcan.2020.05.036. Epub 2020 Jun 4. Lung Cancer. 2020. PMID: 32534795 Free article.
p53 mutations in human lung tumors.
Miller CW, Simon K, Aslo A, Kok K, Yokota J, Buys CH, Terada M, Koeffler HP. Miller CW, et al. Among authors: kok k. Cancer Res. 1992 Apr 1;52(7):1695-8. Cancer Res. 1992. PMID: 1312896
435 results